A longtime leader in healthcare improvement, we’re developing new ways to revolutionize the industry.
Premier recommends ways for FDA to incorporate emerging technologies into drug development and provide clarity for manufacturers.
Premier urges the DEA to ensure reductions in opioid manufacturing quotas do not exacerbate recent drug shortages.
Builds on efforts to create healthier pharmaceutical markets that ensure continuous access and prevent shortages that can compromise patient care.
Premier responds to CMS' final rule to compensate hospitals for past underpayments for 340B drugs.
Examine key AI trends and use cases – all aimed at helping you understand the opportunities AI offers to improve the health of communities you serve.
We're here to help you use AI to its fullest in improving the health of communities you serve. Get started with our eBook.
Premier experts along with members of Congress, healthcare organizations and others explored the AI landscape, including critical policy and regulatory issues, during a Congressional briefing.
Happy National Pharmacy Week 2023. And thank you to all pharmacists for your tireless work and dedication to improving the health of communities you serve.
See how Premier, Exela® Pharma Sciences and Premier members are protecting the future of the pharmaceutical supply chain together.
Pharmacy Purchasing & Products Magazine |
Premier's Kevin Hansen and Cone Health's Austin S. Price highlight how compounders can achieve longer beyond-use dates (BUDs) for compounded sterile preparations through enhanced quality...
Premier urged CMS to adopt policies to ensure that hospitals and other 340B entities are appropriately compensated for past 340B payment shortfalls.
Premier responded to the FDA’s draft guidance on the statutory prohibition on wholesaling for certain compounded drugs.